 | ZU5 | Name: | N-[(benzyloxy)carbonyl]-O-tert-butyl-L-threonyl-N-[(1R)-4-cyclopropyl-4-oxo-1-{[(3S)-2-oxopyrrolidin-3-yl]methyl}butyl]-L-leucinamide | Formula: | C34 H52 N4 O7 | SMILES: | O=C(OCc1ccccc1)NC(C(=O)NC(C(=O)NC(CC2C(=O)NCC2)CCC(=O)C3CC3)CC(C)C)C(OC(C)(C)C)C | InChi: | InChI=1S/C34H52N4O7/c1-21(2)18-27(31(41)36-26(14-15-28(39)24-12-13-24)19-25-16-17-35-30(25)40)37-32(42)29(22(3)45-34(4,5)6)38-33(43)44-20-23-10-8-7-9-11-23/h7-11,21-22,24-27,29H,12-20H2,1-6H3,(H,35,40)(H,36,41)(H,37,42)(H,38,43)/t22-,25+,26-,27+,29+/m1/s1 | Synonyms: | TG-0205486 | Definition date: | 2008-12-10 | Last modified: | 2024-09-27 | Identifier: | N-[(benzyloxy)carbonyl]-O-tert-butyl-L-threonyl-N-{(2R)-5-cyclopropyl-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pentan-2-yl}-L-leucinamide |
|
 | ZBZ | Name: | S-(phenylcarbonyl)-L-cysteine | Formula: | C10 H11 N O3 S | SMILES: | O=C(O)C(N)CSC(=O)c1ccccc1 | InChi: | InChI=1S/C10H11NO3S/c11-8(9(12)13)6-15-10(14)7-4-2-1-3-5-7/h1-5,8H,6,11H2,(H,12,13)/t8-/m0/s1 | Definition date: | 2010-02-09 | Last modified: | 2024-09-27 | Identifier: | S-benzoyl-L-cysteine |
|
 | VXT | Name: | 2-(hydroxymethyl)-1-[6-[4-[[3-[[3-[6-[(2~{S},3~{R},4~{S})-2-(hydroxymethyl)-3,4-bis(oxidanyl)pyrrolidin-1-yl]hexyl]-1,2,3-triazol-4-yl]methoxy]-2,2-bis[[1-[6-[2-(hydroxymethyl)-3,4-bis(oxidanyl)pyrrolidin-1-yl]hexyl]-1,2,3-triazol-4-yl]methoxymethyl]propoxy]methyl]-1,2,3-triazol-1-yl]hexyl]pyrrolidine-3,4-diol | Formula: | C61 H108 N16 O16 | SMILES: | OCC1C(O)C(O)CN1CCCCCCn2cc(COCC(COCc3cn(CCCCCCN4CC(O)C(O)C4CO)nn3)(COCc5cn(CCCCCCN6CC(O)C(O)C6CO)nn5)COCc7cnnn7CCCCCCN8C[CH](O)[CH](O)[CH]8CO)nn2 | InChi: | InChI=1S/C61H108N16O16/c78-33-49-57(86)53(82)29-70(49)17-9-1-5-13-21-74-26-45(63-67-74)37-90-41-61(42-91-38-46-27-75(68-64-46)22-14-6-2-10-18-71-30-54(83)58(87)50(71)34-79,43-92-39-47-28-76(69-65-47)23-15-7-3-11-19-72-31-55(84)59(88)51(72)35-80)44-93-40-48-25-62-66-77(48)24-16-8-4-12-20-73-32-56(85)60(89)52(73)36-81/h25-28,49-60,78-89H,1-24,29-44H2/t49?,50?,51?,52-,53?,54?,55?,56-,57?,58?,59?,60+,61?/m0/s1 | Definition date: | 2023-09-20 | Last modified: | 2024-09-27 | Release date: | 2024-10-02 | Identifier: | 2-(hydroxymethyl)-1-[6-[4-[[3-[[3-[6-[(2~{S},3~{R},4~{S})-2-(hydroxymethyl)-3,4-bis(oxidanyl)pyrrolidin-1-yl]hexyl]-1,2,3-triazol-4-yl]methoxy]-2,2-bis[[1-[6-[2-(hydroxymethyl)-3,4-bis(oxidanyl)pyrrolidin-1-yl]hexyl]-1,2,3-triazol-4-yl]methoxymethyl]propoxy]methyl]-1,2,3-triazol-1-yl]hexyl]pyrrolidine-3,4-diol |
|
 | UQ0 | Name: | 2,3-DIMETHOXY-5-METHYL-1,4-BENZOQUINONE | Formula: | C9 H10 O4 | SMILES: | O=C1C=C(C(=O)C(OC)=C1OC)C | InChi: | InChI=1S/C9H10O4/c1-5-4-6(10)8(12-2)9(13-3)7(5)11/h4H,1-3H3 | Definition date: | 2011-11-26 | Last modified: | 2024-09-27 | Release date: | 2023-11-08 | Identifier: | 2,3-dimethoxy-5-methylcyclohexa-2,5-diene-1,4-dione |
|
 | VJ8 | Name: | edaGDP | Formula: | C16 H25 N7 O13 P2 | SMILES: | CCC(=O)NCCNC(=O)O[CH]1[CH](O)[CH](O[CH]1CO[P](O)(=O)O[P](O)(O)=O)n2cnc3C(=O)NC(=Nc23)N | InChi: | InChI=1S/C16H25N7O13P2/c1-2-8(24)18-3-4-19-16(27)35-11-7(5-33-38(31,32)36-37(28,29)30)34-14(10(11)25)23-6-20-9-12(23)21-15(17)22-13(9)26/h6-7,10-11,14,25H,2-5H2,1H3,(H,18,24)(H,19,27)(H,31,32)(H2,28,29,30)(H3,17,21,22,26)/t7-,10-,11-,14-/m1/s1 | Synonyms: | [(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-4-oxidanyl-2-[[oxidanyl(phosphonooxy)phosphoryl]oxymethyl]oxolan-3-yl] ~{N}-[2-(propanoylamino)ethyl]carbamate | Definition date: | 2021-05-18 | Last modified: | 2024-09-27 | Release date: | 2022-08-03 | Identifier: | [(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-4-oxidanyl-2-[[oxidanyl(phosphonooxy)phosphoryl]oxymethyl]oxolan-3-yl] ~{N}-[2-(propanoylamino)ethyl]carbamate |
|
 | OOG | Name: | 2-OXOADIPIC ACID | Formula: | C6 H8 O5 | SMILES: | O=C(C(=O)O)CCCC(=O)O | InChi: | InChI=1S/C6H8O5/c7-4(6(10)11)2-1-3-5(8)9/h1-3H2,(H,8,9)(H,10,11) | Definition date: | 2015-01-21 | Last modified: | 2024-09-27 | Release date: | 2015-01-28 | Identifier: | 2-oxohexanedioic acid |
|
 | NTJ | Name: | R-ETHYL N,N-DIMETHYLPHOSPHONAMIDATE | Formula: | C4 H12 N O2 P | SMILES: | O=P(OCC)N(C)C | InChi: | InChI=1S/C4H12NO2P/c1-4-7-8(6)5(2)3/h8H,4H2,1-3H3 | Definition date: | 2005-09-07 | Last modified: | 2024-09-27 | Identifier: | ethyl (S)-N,N-dimethylphosphonamidoate |
|
 | WSR | Name: | (1R,3aS,3bR,5aR,7R,9aS,9bS,11aR)-1-[(2R)-6-fluoro-5-oxohexan-2-yl]-9a,11a-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-7-yl hydrogen sulfate (non-preferred name) | Formula: | C25 H41 F O5 S | SMILES: | FCC(=O)CCC(C)C1CCC2C3CCC4CC(CCC4(C)C3CCC12C)OS(=O)(=O)O | InChi: | InChI=1S/C25H41FO5S/c1-16(4-6-18(27)15-26)21-8-9-22-20-7-5-17-14-19(31-32(28,29)30)10-12-24(17,2)23(20)11-13-25(21,22)3/h16-17,19-23H,4-15H2,1-3H3,(H,28,29,30)/t16-,17-,19-,20+,21-,22+,23+,24+,25-/m1/s1 | Definition date: | 2022-10-17 | Last modified: | 2024-09-27 | Release date: | 2023-11-01 | Identifier: | (1R,3aS,3bR,5aR,7R,9aS,9bS,11aR)-1-[(2R)-6-fluoro-5-oxohexan-2-yl]-9a,11a-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-7-yl hydrogen sulfate (non-preferred name) |
|
 | KLF | Name: | (2~{S},4~{R})-4-oxidanylpyrrolidine-2-carboxamide | Formula: | C5 H10 N2 O2 | SMILES: | NC(=O)[CH]1C[CH](O)CN1 | InChi: | InChI=1S/C5H10N2O2/c6-5(9)4-1-3(8)2-7-4/h3-4,7-8H,1-2H2,(H2,6,9)/t3-,4+/m1/s1 | Definition date: | 2022-09-27 | Last modified: | 2024-09-27 | Release date: | 2022-10-19 | Identifier: | (2~{S},4~{R})-4-oxidanylpyrrolidine-2-carboxamide |
|
 | UQ1 | Name: | UBIQUINONE-1 | Formula: | C14 H18 O4 | SMILES: | O=C1C(=C(C(=O)C(OC)=C1OC)C)CC=C(/C)C | InChi: | InChI=1S/C14H18O4/c1-8(2)6-7-10-9(3)11(15)13(17-4)14(18-5)12(10)16/h6H,7H2,1-5H3 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 2,3-dimethoxy-5-methyl-6-(3-methylbut-2-en-1-yl)cyclohexa-2,5-diene-1,4-dione |
|
 | VJA | Name: | N-[(benzyloxy)carbonyl]-L-valyl-N-{(2R)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide | Formula: | C26 H40 N4 O6 | SMILES: | c1ccc(cc1)COC(NC(C(C)C)C(=O)NC(C(NC(CO)CC2C(=O)NCC2)=O)CC(C)C)=O | InChi: | InChI=1S/C26H40N4O6/c1-16(2)12-21(24(33)28-20(14-31)13-19-10-11-27-23(19)32)29-25(34)22(17(3)4)30-26(35)36-15-18-8-6-5-7-9-18/h5-9,16-17,19-22,31H,10-15H2,1-4H3,(H,27,32)(H,28,33)(H,29,34)(H,30,35)/t19-,20+,21-,22-/m0/s1 | Definition date: | 2020-08-14 | Last modified: | 2024-09-27 | Release date: | 2021-10-13 | Identifier: | N-[(benzyloxy)carbonyl]-L-valyl-N-{(2R)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide |
|
 | YE3 | Name: | (8M)-8-(2-{[2-(fluorosulfonyl)ethyl]amino}phenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | Formula: | C18 H15 F N2 O5 S | SMILES: | FS(=O)(=O)CCNc1ccccc1c1cccc2c1NC=C(C2=O)C(=O)O | InChi: | InChI=1S/C18H15FN2O5S/c19-27(25,26)9-8-20-15-7-2-1-4-11(15)12-5-3-6-13-16(12)21-10-14(17(13)22)18(23)24/h1-7,10,20H,8-9H2,(H,21,22)(H,23,24) | Definition date: | 2023-12-01 | Last modified: | 2024-09-27 | Release date: | 2024-09-25 | Identifier: | (8M)-8-(2-{[2-(fluorosulfonyl)ethyl]amino}phenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
|
 | XLX | Name: | 4,4'-(ethylenediimino)bis[4-oxobutyrate] | Formula: | C11 H18 N2 O6 | SMILES: | O=C(NCCNC(=O)CCC(=O)O)CCCC(=O)O | InChi: | InChI=1S/C11H18N2O6/c14-8(2-1-3-10(16)17)12-6-7-13-9(15)4-5-11(18)19/h1-7H2,(H,12,14)(H,13,15)(H,16,17)(H,18,19) | Synonyms: | 1,2-bis(maleimido)ethane, hydrolyzed open form | Definition date: | 2012-08-06 | Last modified: | 2024-09-27 | Identifier: | 5-({2-[(3-carboxypropanoyl)amino]ethyl}amino)-5-oxopentanoic acid |
|
 | Y0M | Name: | 8-[fluoro(dihydroxy)-lambda~4~-sulfanyl]-N-(2-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzodioxine-5-sulfonamide | Formula: | C14 H13 F N2 O7 S2 | SMILES: | COc1ncccc1NS(=O)(=O)c1ccc(c2OCCOc12)S(F)(=O)=O | InChi: | InChI=1S/C14H13FN2O7S2/c1-22-14-9(3-2-6-16-14)17-26(20,21)11-5-4-10(25(15,18)19)12-13(11)24-8-7-23-12/h2-6,17H,7-8H2,1H3 | Definition date: | 2022-12-20 | Last modified: | 2024-09-27 | Release date: | 2023-12-06 | Identifier: | 8-[(2-methoxypyridin-3-yl)sulfamoyl]-2,3-dihydro-1,4-benzodioxine-5-sulfonyl fluoride |
|
 | VJB | Name: | bdaGDP | Formula: | C18 H29 N7 O13 P2 | SMILES: | CCC(=O)NCCCCNC(=O)O[CH]1[CH](O)[CH](O[CH]1CO[P](O)(=O)O[P](O)(O)=O)n2cnc3C(=O)N=C(N)Nc23 | InChi: | InChI=1S/C18H29N7O13P2/c1-2-10(26)20-5-3-4-6-21-18(29)37-13-9(7-35-40(33,34)38-39(30,31)32)36-16(12(13)27)25-8-22-11-14(25)23-17(19)24-15(11)28/h8-9,12-13,16,27H,2-7H2,1H3,(H,20,26)(H,21,29)(H,33,34)(H2,30,31,32)(H3,19,23,24,28)/t9-,12-,13-,16-/m1/s1 | Synonyms: | [(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-3~{H}-purin-9-yl)-4-oxidanyl-2-[[oxidanyl(phosphonooxy)phosphoryl]oxymethyl]oxolan-3-yl] ~{N}-[4-(propanoylamino)butyl]carbamate | Definition date: | 2021-05-18 | Last modified: | 2024-09-27 | Release date: | 2022-08-03 | Identifier: | [(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-3~{H}-purin-9-yl)-4-oxidanyl-2-[[oxidanyl(phosphonooxy)phosphoryl]oxymethyl]oxolan-3-yl] ~{N}-[4-(propanoylamino)butyl]carbamate |
|
 | SQI | Name: | hexadecan-1-amine | Formula: | C16 H35 N | SMILES: | CCCCCCCCCCCCCCCCN | InChi: | InChI=1S/C16H35N/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17/h2-17H2,1H3 | Definition date: | 2022-07-07 | Last modified: | 2024-09-27 | Release date: | 2022-12-07 | Identifier: | hexadecan-1-amine |
|
 | NTN | Name: | ISONICOTINAMIDINE | Formula: | C6 H7 N3 | SMILES: | [N@H]=C(N)c1ccncc1 | InChi: | InChI=1S/C6H7N3/c7-6(8)5-1-3-9-4-2-5/h1-4H,(H3,7,8) | Definition date: | 2001-04-16 | Last modified: | 2024-09-27 | Identifier: | pyridine-4-carboximidamide |
|
 | UQ4 | Name: | N-(7-nitro-2,1,3-benzoxadiazol-4-yl)-beta-alanine | Formula: | C9 H8 N4 O5 | SMILES: | C(=O)(CCNc1c2c(c(cc1)N(=O)=O)non2)O | InChi: | InChI=1S/C9H8N4O5/c14-7(15)3-4-10-5-1-2-6(13(16)17)9-8(5)11-18-12-9/h1-2,10H,3-4H2,(H,14,15) | Definition date: | 2020-05-27 | Last modified: | 2024-09-27 | Release date: | 2020-06-03 | Identifier: | N-(7-nitro-2,1,3-benzoxadiazol-4-yl)-beta-alanine |
|
 | OOL | Name: | (E)-1-(4,6-dimethoxypyrimidin-2-yl)methanimine | Formula: | C7 H9 N3 O2 | SMILES: | N=Cc1nc(OC)cc(OC)n1 | InChi: | InChI=1S/C7H9N3O2/c1-11-6-3-7(12-2)10-5(4-8)9-6/h3-4,8H,1-2H3/b8-4+ | Definition date: | 2023-08-17 | Last modified: | 2024-09-27 | Release date: | 2023-11-08 | Identifier: | (E)-1-(4,6-dimethoxypyrimidin-2-yl)methanimine |
|
 | ZCI | Name: | 2-bromo-1H-imidazole | Formula: | C3 H3 Br N2 | SMILES: | Brc1ncc[NH]1 | InChi: | InChI=1S/C3H3BrN2/c4-3-5-1-2-6-3/h1-2H,(H,5,6) | Definition date: | 2023-06-23 | Last modified: | 2024-09-27 | Release date: | 2023-07-12 | Identifier: | 2-bromo-1H-imidazole |
|
 | O95 | Name: | {(4S)-2-[7-(hydroxyamino)-6-methyl-5-(trifluoromethyl)-1,3-benzothiazol-2-yl]-4,5-dihydro-1,3-oxazol-4-yl}(pyrrolidin-1-yl)methanone | Formula: | C17 H17 F3 N4 O3 S | SMILES: | FC(F)(F)c1cc2nc(sc2c(c1C)NO)C4=NC(C(=O)N3CCCC3)CO4 | InChi: | InChI=1S/C17H17F3N4O3S/c1-8-9(17(18,19)20)6-10-13(12(8)23-26)28-15(22-10)14-21-11(7-27-14)16(25)24-4-2-3-5-24/h6,11,23,26H,2-5,7H2,1H3/t11-/m0/s1 | Definition date: | 2014-04-04 | Last modified: | 2024-09-27 | Release date: | 2015-10-28 | Identifier: | {(4S)-2-[7-(hydroxyamino)-6-methyl-5-(trifluoromethyl)-1,3-benzothiazol-2-yl]-4,5-dihydro-1,3-oxazol-4-yl}(pyrrolidin-1-yl)methanone |
|
 | MME | Name: | N-METHYL METHIONINE | Formula: | C6 H13 N O2 S | SMILES: | O=C(O)C(NC)CCSC | InChi: | InChI=1S/C6H13NO2S/c1-7-5(6(8)9)3-4-10-2/h5,7H,3-4H2,1-2H3,(H,8,9)/t5-/m0/s1 | Definition date: | 1999-10-14 | Last modified: | 2024-09-27 | Identifier: | N-methyl-L-methionine |
|
 | ZCL | Name: | 3,4-dichloro-L-phenylalanine | Formula: | C9 H9 Cl2 N O2 | SMILES: | Clc1ccc(cc1Cl)CC(C(=O)O)N | InChi: | InChI=1S/C9H9Cl2NO2/c10-6-2-1-5(3-7(6)11)4-8(12)9(13)14/h1-3,8H,4,12H2,(H,13,14)/t8-/m0/s1 | Definition date: | 2010-12-29 | Last modified: | 2024-09-27 | Identifier: | 3,4-dichloro-L-phenylalanine |
|
 | T4M | Name: | N-[(1R)-1-(naphthalen-1-yl)ethyl]acetamide | Formula: | C14 H15 N O | SMILES: | c1(cccc2c1cccc2)C(NC(=O)C)C | InChi: | InChI=1S/C14H15NO/c1-10(15-11(2)16)13-9-5-7-12-6-3-4-8-14(12)13/h3-10H,1-2H3,(H,15,16)/t10-/m1/s1 | Definition date: | 2020-03-16 | Last modified: | 2024-09-27 | Release date: | 2020-03-25 | Identifier: | N-[(1R)-1-(naphthalen-1-yl)ethyl]acetamide |
|
 | Y0P | Name: | 8-[bis(oxidanyl)-$l^{3}-sulfanyl]-~{N}-(3-fluoranyl-5-methoxy-phenyl)-2,3-dihydro-1,4-benzodioxine-5-sulfonamide | Formula: | C15 H13 F2 N O7 S2 | SMILES: | Fc1cc(cc(OC)c1)NS(=O)(=O)c1ccc(c2OCCOc12)S(F)(=O)=O | InChi: | InChI=1S/C15H13F2NO7S2/c1-23-11-7-9(16)6-10(8-11)18-27(21,22)13-3-2-12(26(17,19)20)14-15(13)25-5-4-24-14/h2-3,6-8,18H,4-5H2,1H3 | Definition date: | 2022-12-20 | Last modified: | 2024-09-27 | Release date: | 2023-12-06 | Identifier: | 8-[(3-fluoro-5-methoxyphenyl)sulfamoyl]-2,3-dihydro-1,4-benzodioxine-5-sulfonyl fluoride |
|